Tuesday, June 6, 2023 | Back issues
Courthouse News Service Courthouse News Service

Federal Circuit

PATENT, TRADE - The Federal Circuit found that imported recombinant human erythropoietin was properly held as exempt from patent infringement by the safe-harbor statute, but that defendants' uses of imports unrelated to obtaining FDA approval are not shielded. The International Trade Commission should not have dismissed the issue on jurisdictional grounds.

Categories: Uncategorized

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.